Company / EPS (Basic)
Tyra Biosciences, Inc. EPS (Basic) History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$1.51
FY2024
5-year range
-$1.91 / -$1.32
FY2021-FY2024
Trend
+6.8%
vs FY2023
Sector context
#110 of 208
Health Care
What the data says
At $-1.51, Tyra Biosciences, Inc.'s eps (basic) ranks #110 of 208 in the Health Care sector. Declined from $-1.32 to $-1.51 over the past 2 years.
Based on SEC 10-K filings.
-1.51 in FY2024.
Declined from $-1.32 to $-1.51 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#110 of 208 in Health CareTop 53% of 208This company -$1.51 Sector average -$0.87
▼
-73.4% below sector average
Key checks
Key Insights
- In FY2024, eps (basic) increased 6.8% year-over-year.
- Ranks #110 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 6.83 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.51 | +6.8% |
| FY2023 | -$1.62 | -22.7% |
| FY2022 | -$1.32 | +30.9% |
| FY2021 | -$1.91 | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026